Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis B Silverman

Showing results (31-40 of 188) with videos related to

Pageof 19
Sort By:
Journal of Clinical Pathology|June 24, 2026
Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfallEmily M Harris, Matthew M Heeney, Andrew E Place, et al.
Blood|March 15, 2003
Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulationAdolfo A Ferrando, Scott A Armstrong, Donna S Neuberg, et al.
Pediatric Blood & Cancer|December 12, 2018
A single institutional review of pediatric Bacillus spp. bloodstream infections demonstrates increased incidence among children with cancerDavid S Shulman, Preeti Mehrotra, Traci M Blonquist, et al.
Blood|December 13, 2003
FLT3 mutations in childhood acute lymphoblastic leukemiaScott A Armstrong, Meghann E Mabon, Lewis B Silverman, et al.
British Journal of Haematology|January 8, 2011
The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocolsRachael F Grace, Suzanne E Dahlberg, Donna Neuberg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 12, 2016
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemiaStephen A Sands, Brian T Harel, Mirko Savone, et al.
Frontiers in Pediatrics|January 28, 2026
Outcomes of T-cell lymphoblastic lymphoma in children and adolescents treated with Dana-Farber Cancer Institute Childhood ALL Consortium protocolsGiacomo Gotti, Yael Flamand, Victoria Koch, et al.
Pediatric Blood & Cancer|December 14, 2016
A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemiaYaron Finkelstein, Traci M Blonquist, Veena Vijayanathan, et al.
Pediatric Blood & Cancer|July 2, 2011
Neuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana-Farber ALL consortium protocol 95-01 at 5 years post-diagnosisDeborah P Waber, Jennifer Turek Queally, Lori Catania, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2003
Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experienceJohn M Goldberg, Lewis B Silverman, Donna E Levy, et al.
Pageof 19

Showing results (31-40 of 188) with videos related to

Sort By:
Pageof 19
Journal of Clinical Pathology|June 24, 2026
Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfallEmily M Harris, Matthew M Heeney, Andrew E Place, et al.
Blood|March 15, 2003
Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulationAdolfo A Ferrando, Scott A Armstrong, Donna S Neuberg, et al.
Pediatric Blood & Cancer|December 12, 2018
A single institutional review of pediatric Bacillus spp. bloodstream infections demonstrates increased incidence among children with cancerDavid S Shulman, Preeti Mehrotra, Traci M Blonquist, et al.
Blood|December 13, 2003
FLT3 mutations in childhood acute lymphoblastic leukemiaScott A Armstrong, Meghann E Mabon, Lewis B Silverman, et al.
British Journal of Haematology|January 8, 2011
The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocolsRachael F Grace, Suzanne E Dahlberg, Donna Neuberg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 12, 2016
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemiaStephen A Sands, Brian T Harel, Mirko Savone, et al.
Frontiers in Pediatrics|January 28, 2026
Outcomes of T-cell lymphoblastic lymphoma in children and adolescents treated with Dana-Farber Cancer Institute Childhood ALL Consortium protocolsGiacomo Gotti, Yael Flamand, Victoria Koch, et al.
Pediatric Blood & Cancer|December 14, 2016
A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemiaYaron Finkelstein, Traci M Blonquist, Veena Vijayanathan, et al.
Pediatric Blood & Cancer|July 2, 2011
Neuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana-Farber ALL consortium protocol 95-01 at 5 years post-diagnosisDeborah P Waber, Jennifer Turek Queally, Lori Catania, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2003
Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experienceJohn M Goldberg, Lewis B Silverman, Donna E Levy, et al.
Pageof 19